Cardiovascular health, heart failure, atherosclerosis, and cardiac research
254 articles
New study shows evolocumab significantly reduces cardiovascular events in diabetes patients, offering powerful prevention strategy.
Major cardiology groups recommend cholesterol screening in childhood for some, plus new genetic risk factors like lipoprotein(a) testing.
Leading cardiologists highlight persistent challenges in determining optimal lipid-lowering strategies for cardiovascular disease prevention.
New analysis challenges assumptions about sudden cardiac death risk in heart failure patients with preserved pumping ability.
Major study shows tirzepatide reduces cardiovascular and kidney complications by 16% compared to dulaglutide in diabetic patients.
Neurofilament light chain levels in blood strongly predict cardiovascular events and death in people with atrial fibrillation over 8 years.
Post-analysis of major trial shows extended apixaban treatment may prevent superficial vein thrombosis in patients with ongoing clotting risks.
Women who experience spontaneous coronary artery dissection during pregnancy face worse heart damage and slower recovery than non-pregnant cases.
New study uses cutting-edge imaging to solve the mystery of heart attacks that occur despite normal-looking coronary arteries.
Sotatercept emerges as potential treatment for combined pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction.
Sotatercept reduced dangerous pressure in heart failure patients' lungs and improved walking ability in phase 2 study.
New research reveals how elevated Lp(a) levels interact with hormonal changes to significantly increase venous thromboembolism risk.
